Trial Information
Summary: Gout
Ridgeview Research is participating in a clinical research study for an investigational medication. This medication will be compared to a commonly used marketed medication. There is no placebo (inactive substance).
Study Length:
14 days
# Visits:
8 days of study medication
Patient Inclusion Criteria:
- 18 years of age or older
- History of gouty arthritis or current symptoms of gout.
- Females must be postmenopausal, surgically sterile or using birth control since their last period prior to start of study and during the study.
Patient Exclusion Criteria:
- Diagnosis of any other type of arthritis
- Any sensitivity to previously taken NSAIDs (aspirin, ibuprofen, naproxen)
- Have had a stroke or have any other heart conditions
|
Contact:
Ridgeview Research
3000 Hundertmark Road
Chaska, MN 55318
Telephone: (952) 556-2687
Fax: (952) 556-2688
Email:
|
|

If you would like to learn more about participating in this study, please send an e-mail message using the form below.
Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.
This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.
Trial listings updated: June 1, 2008 at 6:42:42 AM